Skip to content

Dr. Coldea Pediatrics

Active
Private limited companyfounded 20242 yrs activede Broquevillelaan 204, 1200 Sint-Lambrechts-Woluwe, BelgiumKBO/BCE: BE 1013.812.722
Summary

Dr. Coldea Pediatrics has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€1,384) and a net result of -€3,384. Its solvency ranks better than 5% of 18230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Overview

What they do
Specialist medical practice
NACE 86220
1 site
How big
€61,221total assets 2025
Equity
-€1,384
Loss
-€3,384
Turnover not published (abridged schema)
Financially healthy?
44 Weak Checked score 2025
Bankruptcy chance 12 m
0.5%
Who decides
Accounts filed 37 d late0 of 2 deeds read
Why 44- Young company- Higher-failure-rate region- Annual accounts: weaker financial profile- Negative equity+ Lower-failure-rate sectorFiled after the deadlineShow the evidence

Checked score

Score 2025
44 / 100
Weak
Negative equity caps the score. Every signal that weighs is under Signals.
Axes
Profitability62
Solvency23
Growth-
Track record67
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity tight (current ratio 1.31; short-term debt: 50.4% and cash: 5.1% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-2.3%
Return on assets
-5.5%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-09-2026, 37 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
37 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€1,384 View
  • Caution: Among the weakest 5% on solvencysector median 63.8% · 18,230 companies -2.3% View
  • Total assets 2025first fiscal year filed €61,221 View

By topic

Financials

Fiscal year
2025
Total assets
€61,221
Loss
-€3,384
Solvency
-2.3%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
19-09-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.